Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: January 2020

MissionIRNewsBreaks – Predictive Oncology Inc. (NASDAQ: POAI) Aims to Commercialize AI-Driven Predictive Model of Ovarian Cancer in Q1 2020

Predictive Oncology (NASDAQ: POAI), a data and artificial-intelligence- (“AI”) driven, discovery-services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, recently issued an update regarding its groundbreaking CancerQuest 2020 initiative driven by its Helomics … Continue reading

Posted in MissionIRNewsBreaks, Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Platform Leads the Way in Data Privacy

SRAX (NASDAQ: SRAX), a digital-marketing and consumer-data-management technology company, is staying ahead of the curve on privacy laws with its patented BIGtoken platform. A recent article discussing the company reads, “An additional concern is new privacy laws across the country, … Continue reading

Posted in MissionIRNewsBreaks, SRAX, Inc. SRAX | Leave a comment

ChineseInvestors.com Inc. (CIIX) to Market CBD, Build Sales through Social Media Strategies

CIIX CEO said company will employ social media as it markets new CBD products starting March 2020 CIIX subsidiary CBD Biotech Co. focused on driving growth, building online sales to younger demographics in China Goals of CIIX strategy include profitability, … Continue reading

Posted in Chineseinvestors.com, Inc. CIIX | Leave a comment

Predictive Oncology Inc. (NASDAQ: POAI), Leader in Precision Medicine, Committed to Playing Key Role in Decreasing Cancer Deaths

American Cancer Society annual report shows largest single-year drop in cancer deaths ever reported Doctors attribute precision medicine with playing significant role in decline POAI leading player in precision medicine, initiated groundbreaking Cancer Quest 2020 project A new American Cancer … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Innovative UST Platform Featured in Leading North American Cannabis Publication

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that its new and innovative Ultra Shear Technology(TM) (“UST”) … Continue reading

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Provides Update on Portfolio Companies

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning provided an update regarding recent announcements from its portfolio companies High Beauty, Inc., TerrAscend Corp. (CSE: TER), YSS Corp. (TSX.V: YSS) and James E. Wagner … Continue reading

Posted in Canopy Rivers Inc. CNPOF, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) President, CEO Discusses Disruptive 3D Metal-Printing Technology in NNW Interview

John Rice, president and CEO of Sigma Labs (NASDAQ: SGLB), a leading developer of quality-control software for the commercial 3D-printing industry, recently discussed the company’s novel technology in a NetworkNewsAudio interview with Stuart Smith. An article discussing the company reads, … Continue reading

Posted in MissionIRNewsBreaks, Sigma Labs Inc. SGLB | Leave a comment

MissionIRNewsBreaks – Zacks Small Cap Research Issues Update, Maintains Price Target on Pressure BioSciences Inc. (PBIO)

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the life sciences and other industries, was recently covered in a research report by Zacks Small Cap Research, a … Continue reading

Posted in MissionIRNewsBreaks, Pressure BioSciences Inc. PBIO | Leave a comment

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Expects Sustainable Revenue Growth, Plans New Capital Markets Strategy in 2020

Growing interest in the company’s innovative DehydraTECH™ drug delivery platform from large global corporations Lexaria’s strategy to be listed on a nationally recognized U.S. exchange will help the company access a significantly larger audience of investors Lexaria has 16 patents … Continue reading

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment

Concerns About Vape Addiction, Injury Provide Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) with Opportunity

Lexaria Bioscience continues to advance the effectiveness of its proprietary DehydraTECH technology, a formulation that teams with drug substances such as nicotine and cannabidiol to quickly carry those drugs into a user’s blood stream Recent concerns about the safety of … Continue reading

Posted in Lexaria Bioscience Corp. (LXRP) | Leave a comment